Division 04 of 400

Advancing Human
Longevity & Wellness

Zenth Health Sciences integrates precision medicine, AI-driven drug discovery, and global healthcare delivery to redefine the boundaries of modern medicine. Operating across 45 countries, we pioneer therapies that extend healthy lifespans.

0 R&D Centers
0 Patents Filed
0 Patients Served
0 Annual Revenue

Integrated Healthcare Ecosystem

Five interconnected verticals driving breakthrough therapies, diagnostics, and care delivery worldwide.

πŸ’Š
Pharma & Therapeutics

Targeted small molecules, biologics, and orphan drugs developed through proprietary AI screening platforms. 14 compounds in Phase III trials.

Oncology Neuro Cardio Rare Diseases
🧬
Gene & Cell Therapy

CRISPR-Cas9 delivery systems, CAR-T cell manufacturing, and regenerative tissue engineering for inherited and degenerative conditions.

CRISPR CAR-T Stem Cells Viral Vectors
πŸ€–
MedTech & Diagnostics

AI-powered imaging, surgical robotics, wearable biosensors, and rapid-pathology platforms accelerating accurate clinical decision-making.

AI Imaging Robotics Wearables Point-of-Care
🌐
Digital Health & Telemedicine

Global telehealth network, remote patient monitoring, and predictive analytics engine serving 18M+ connected devices and clinicians.

Telehealth EHR Predictive AI mHealth
πŸ₯
Global Hospital Network

34 research-integrated medical centers and specialty clinics delivering premium care, complex procedures, and clinical trial participation.

Research Hospitals Specialty Care Transplant Recovery

Project AETHEREAL

Our proprietary AI-driven molecular simulation platform reduces early-stage drug discovery from 5 years to 18 months. By integrating quantum computing with multi-omics data, AETHEREAL predicts protein folding, drug toxicity, and clinical efficacy with 94.7% accuracy.

18mo
Discovery Cycle
94.7%
Prediction Accuracy
3
FDA Approvals
62
Active Programs

Research & Clinical Centers

Strategically positioned facilities enabling 24/7 research, manufacturing, and patient care across six continents.

πŸ‡ΊπŸ‡Έ
Boston, MA
Global HQ & Biotech Hub

Primary R&D campus housing 12,000 researchers, FDA-regulated manufacturing, and the AETHEREAL supercomputing center.

πŸ‡¬πŸ‡§
Cambridge, UK
Gene Therapy & Academia

Joint venture with Cambridge University focusing on CRISPR delivery mechanisms and pediatric genetic disorders.

πŸ‡ΈπŸ‡¬
Jurong, Singapore
APAC Manufacturing

State-of-the-art GMP facility producing biologics, vaccines, and advanced cell therapies for Asian and Pacific markets.

πŸ‡¨πŸ‡­
Basel, Switzerland
Clinical Trials & Regulation

EMA liaison office, multi-center trial coordination, and precision oncology research partnered with Swiss Federal Institutes.

πŸ‡―πŸ‡΅
Tokyo, Japan
Longevity & Regenerative Med

Focus on senolytics, tissue regeneration, and aging research in collaboration with Tokyo University and national health institutes.

πŸ‡¦πŸ‡ͺ
Dubai, UAE
Middle East Clinical Hub

Premium hospital network, desert-climate health research, and regional telemedicine distribution center.

Guiding Innovation in Healthcare

World-class scientists, clinicians, and executives steering Zenth Health Sciences toward medical breakthroughs.

πŸ‘©β€βš•οΈ
Dr. Elena Vasquez
Chief Medical Officer

Former NIH director with 20+ years in translational medicine and global health policy. Leads clinical strategy and regulatory compliance.

πŸ‘¨β€πŸ”¬
Dr. Kenji Tanaka
Head of R&D

Pioneer in CRISPR gene editing and molecular biology. Published 300+ papers and holds 47 active patents in genomic medicine.

πŸ‘©β€πŸ’Ό
Sarah Chen
Division President

Healthcare strategy executive with experience scaling biotech ventures. Oversees $4.1B annual P&L and cross-divisional integration.

Join the Future of Medicine

Whether you're a research institution, clinical partner, or prospective team member, Zenth Health Sciences offers unprecedented resources to accelerate human health.

Explore Partnerships β†’ View Open Roles